Results 31 to 40 of about 7,125 (253)

The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia—Case report and review of literature

open access: yeseJHaem, 2022
Priapism is a rare presenting feature of chronic myeloid leukemia (CML) in male patients. Treatment aims to relieve symptoms and to prevent erectile dysfunction. Several treatment modalities exist, however no standard treatment is recommended.
Marleen G. A. M. van derVelde   +3 more
doaj   +1 more source

Congenital leukemia presenting as fever in a neonate [PDF]

open access: yes, 2015
Background Emergency department workup of pediatric fever typically focuses on ruling out serious bacterial infection, but other disease processes can cause fever. Congenital leukemia is a rare but important cause of fever in neonates.
Beard, Bethany, Turner, Joseph
core   +1 more source

Leukemoid Reaction: Presentation of Two Cases [PDF]

open access: yes, 2017
The leukemoid reaction is defined by the presence in peripheral blood of white cells above 50,000/mm3 or neutrophils above 30,000/mm3 . The frequency varies between 1.3 and 15% of newborns admitted to neonatal intensive care units [1]. It usually appears
Arca Díaz, Gemma   +2 more
core   +1 more source

Exchange transfusion as a treatment strategy in severe pertussis with hyperleukocytosis in an infant -A case report

open access: yesJournal of Pediatric Critical Care, 2019
Hyperleukocytosis in pertussis has a correlation with disease severity. We describe a 5-week-old infant with severe pertussis and hyperleukocytosis requiring mechanical ventilation. Baby developed refractory hypoxemia.
Abdul Rauf, Anil Sachdev, Dhiren Gupta
doaj   +1 more source

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high risk acute myeloid leukemia. [PDF]

open access: yes, 2006
Epigenetic alterations of chromatin due to aberrant histone deacetylase (HDAC) activity and transcriptional silencing of all-trans retinoic acid (ATRA) pathway are events linked to the pathogenesis of acute myeloid leukemia (AML) that can be targeted by ...
Aloe Spiriti, M   +17 more
core   +1 more source

Hyperleukocytosis in patients with acute myeloid leukemia admitted to the intensive care unit: a single-center retrospective analysis.

open access: yesLeukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2023
A relevant proportion of patients with acute myeloid leukemia (AML) presenting with hyperleukocytosis are admitted to the intensive care unit (ICU). However, data on characteristics and outcomes of these patients are limited.
J. Heger   +9 more
semanticscholar   +1 more source

Hyperleukocytosis: Emergency Management : Authors’ Reply [PDF]

open access: yesThe Indian Journal of Pediatrics, 2013
To the Editor:We thank Gupta et al. for their comments. In a patient with acute leukemia, hyperleukocytosis and Hb >7 g/dL, hydration is initiated at 2–4 times of normal maintenance. Leukoreduction by either leukapheresis or exchange transfusion is considered if the patient has symptoms related to leukostasis.
Deepak, Bansal, Richa, Jain
openaire   +2 more sources

Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. [PDF]

open access: yes, 2016
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files.
Arvidson, Johan   +12 more
core   +1 more source

Clinical and laboratory effects of exchange transfusion in pediatric acute lymphoblastic leukemia with hyperleukocytosis

open access: yesPaediatrica Indonesiana, 2023
Background Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Emergency complications such as hyperleukocytosis can arise as the disease develops. Exchange transfusion is one of many cytoreductive modalities to resolve the condition.
Rasya Azka Lazuwardi   +2 more
semanticscholar   +1 more source

Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients

open access: yesFrontiers in Oncology, 2022
Clinical pathways are evidence-based tools that have been integrated into many aspects of pediatric hospital medicine and have proven effective at reducing in-hospital complications from a variety of diseases.
Agnes Reschke   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy